SUMMARY The role of macrophages and of macrophage-lymphocyte co-operation in the induction of T-suppressor cell activity in rats with adjuvant arthritis was investigated. Macrophages from arthritic rats had no direct effect on the induction of T-suppressor cells, but, in the presence of arthritic rats' lymphocytes or supernatants from such lymphocytes, macrophages inhibited the induction of T-suppressor cell activity. Addition of indomethacin during the induction of T-suppressor cells reduced the inhibitory effects, suggesting that prostaglandins released from lymphocyte-activated macrophages might be involved in the defective induction of T-suppressor cell activity in rats with adjuvant arthritis.
Previous investigations have shown that rats with adjuvant arthritis have a decreased level of T-suppressor cell activity after induction of suppressor cells in vitro with the polyclonal activator concanavalin-A (con-A). ' The appearance of decreased T-suppressor cell activity during the course of the disease was found to coincide with the development of the polyarthritic lesions and the extent of impairment of T-suppressor cell function was positively correlated with the severity of the lesions. This model may be of value for the investigation of suppressor cell function during chronic inflammatory diseases and may permit more detailed studies of drugs used in the treatment of conditions involving impaired suppressor cell function. 2 However, the mechanism by which the induction of T-suppressor cell activity is affected during the course of adjuvant arthritis has not been studied in detail. Removal of phagocytic cells (of the monocyte/macrophage series) from the arthritic cell suspensions prior to induction of T-suppressor cells with con-A led to a normal level of suppressor cell activity.1 These results point to an important role for the macrophage in the immunoregulatory processes during adjuvant arthritis. A similar role for the macrophage during chronic inflammatory diseases in man has recently been suggested.34
In the present experiments I have investigated the ability of macrophages obtained from arthritic Accepted for publication 11 January 1983. Correspondence to Dr L. Binderup. rats to inhibit the induction of T-suppressor cells, either by direct cell-to-cell contact or via the release of soluble factors. It was found that the macrophage exerted its suppressive effects only in the presence of arthritic lymphocytes. Supernatants from these lymphocytes could substitute for the presence of the arthritic lymphocytes during induction. Incubation with indomethacin partially reversed the inhibitory effects on the induction of T-suppressor cell activity, suggesting that prostaglandins released from macrophages were involved in the observed decrease of T-suppressor cell activity in rats with adjuvant arthritis. T-suppressor cells were induced in cultures of purified lymphocytes (20 x 10 cells/ml) from control or arthritic rats by incubation for 24 hours with 5 ,ug/ml con-A, grade IV (Sigma). In some experiments the lymphocytes were incubated with monolayers of adherent cells prepared from 20 x 10 unseparated spleen cells/ml. In other experiments the lymphocytes were resuspended in supematants obtained either from adherent spleen cells or from-purified spleen lymphocytes. After culture with con-A the cells were collected, washed, treated with mitomycin C (30 ,g/ml for 30 min at 37°C), and adjusted to 4 x 10' cells/ml. Aliquots of 50 ,l were added to .cultures containing 100,u1 Lewis spleen cells and 100 ,ul Lewis x Brown Norway (F1) spleen cells (MLR cultures, 4 x 106 cells/ml in culture medium supplemented with 5 x 107 M 2-mercaptoethanol).
The cultures were incubated for 96 hours, the last 4 hours in the presence of 3H-thymidine (3H-TdR, 1 ,uCi/ml, 5000 mCi/mmol, the Radiochemical Centre, Amersham, England). 3H-TdR incorporation into cellular DNA was determined as previously described' and expressed as disintegrations per minute (dprn)/culture + SEM. All determinations were performed in triplicate and Student's t test was used for statistical analysis. Cell viability was assessed before culture and at the end of incubation by the eosin Y exclusion method.
Results

EFFECTS OF MACROPHAGES ON T-SUPPRESSOR CELL INDUCTION
Purified spleen lymphocytes (depleted of macrophages by treatment with carbonyl iron and by adherence to plastic) were obtained from control rats and from rats with adjuvant arthritis and cultured in the absence or presence of monolayers of adherent spleen cells from arthritic rats. T-suppressor cells were induced in these cultures by the addition of con-A (0 or 5 Ag/ml). Their suppressive activity was tested 24 hours later by addition to MLR cultures consisting of Lewis and Lewis x Brown Norway (F1) rat spleen cells. Fig. 1 shows that con-A induced purified spleen lymphocytes from both control and arthritic rats inhibited the 3H-TdR incorporation in the MLR cultures to the same extent (by 52% and 43%, respec- These results suggest that purified spleen lymphocytes from arthritic rats may, via the production of a soluble factor, induce or 'activate' macrophages to interfere with the normal induction of T--suppressor cell activity.
EFFECT OF INDOMETHACIN ON T-SUPPRESSOR CELL INDUCTION
Since macrophages are known to be able to release prostaglandins with immunosuppressive activities Qn interaction with a variety of stimuli, the possibility was investigated that prostaglandins were involved in the decreased induction of T-suppressor cell activity during adjuvant ar-thritis. Indomethacin (1 ,g/ml) was added to cultures of purified spleen lymphocytes from control or arthritic rats, in the presence of adherent spleen cells, during the induction of T-suppressor cells with con-A. Table 2 shows that indomethacin had no effect on T-suppressor cell activity when added to cultures of control lymphocytes and.control adherent cells (54% inhibition of MLR 3H-TdR incorporation with cells from cultures The present experiments deal with the role of macrophages and lymphocyte/macrophage co-operation in the induction of T-suppressor cell activity in rats with adjuvant arthritis. Macrophages, as characterised by morphology, adherence to plastic, phagocytic uptake of carbonyl iron particles, and presence of membrane-associated esterase, were previously found to be involved in the decreased induction of T-suppressor cells, as removal prior to induction with con-A resulted in a normal level of T-suppressor cell activity.1 The present investigations show that macrophages from arthritic rats did not directly, or by the release of soluble inhibitors, interfere with the induction of T-suppressor cells. This phenomenon occurred only when lymphocytes from arthritic rats were added to the cultures, and could be replaced by supernatants obtained from such lymphocytes but not by supematants from control lymphocytes. The supematant activity was found to be nondialysable and unstable upon prolonged storage. Lymphocyte-derived factors that exert nonspecific or specific suppressor activity, possibly through the activation of macrophages, have repeatedly been described.12 These factors include lymphokines, such as soluble immune response suppressor (SIRS), low-molecular-weight activator of suppressor monocytes (LASM), and macrophage activating/arming factor (MAF). Imbalance in the production or activity of these factors may be involved in the pathogenesis of a number of immunological disorders, as suggested by the decrease in SIRS production and suppressor cell activity in old NZB/NZW mice with autoimmune murine lupus. In conclusion, the present experiments suggest that lymphocytes from arthritic rats produce a soluble factor(s) that induce or activate macrophages to exert an inhibitory effect on the generation of T-suppressor cells, possibly through the release of prostaglandins and/or other macrophage-derived mediators. This model may be of value for the investigation of suppressor cell activity in chronic inflammatory disease and lends itself to the investigation of immunoregulatory drugs. The described experimental system should enable us to distinguish between treatments that interfere with the induction of activating factors released by arthritic rats' lymphocytes and treatments that may interfere with the effector functions of the macrophage. 
